FIELD: medicine, pharmacology.
SUBSTANCE: mentioned medicinal preparations (versions) include immunogenic protein or nucleic acid, coding the corresponding immunogenic protein (the sequences are presented in sequences list). Medicinal preparations, based on immunogenic protein or protein coding nucleic acid, are used in immunogenic formulation for humoral immunity induction, applied as pharmaceutical means. The invention also covers method of infectivity neutralisation of mentioned bacteria and method of patient immunisation against Chlamydia trachomatis infection by applying immunogenic compositions.
EFFECT: applying antigens and immunogens, identified by the invention, provides producing of more effective vaccines, diagnostic and treatment preparations.
7 cl, 162 dwg, 2 tbl, 44 ex
Title | Year | Author | Number |
---|---|---|---|
OUTER MEMBRANE VESICLE VACCINE (OMV) CONTAINING PROTEINS OF SEROGROUP B N.Meningitis OUTER MEMBRANE | 2001 |
|
RU2279889C2 |
NEISSERIA ANTIGENS | 1998 |
|
RU2347813C2 |
NEISSERIA ANTIGENE PEPTIDES | 2000 |
|
RU2281956C2 |
PROTEIN OBTAINED FROM NEISSERIA MENINGITIDIS SHOWING ANTIGEN PROPERTY, ANTIBODY, NUCLEIC ACID FRAGMENT (VARIANTS) AND COMPOSITION CONTAINING THEREOF | 1999 |
|
RU2233331C2 |
NEISSERIA ANTIGENIC PEPTIDES | 2000 |
|
RU2284332C2 |
PROTEIN PRODUCTION | 2005 |
|
RU2429243C2 |
PROTEIN OBTAINED FROM NEISSERIA MENINGITIDIS ELICITING PROPERTIES OF ANTIGEN, ANTIBODY, NUCLEIC ACID (VARIANTS) AND COMPOSITION CONTAINING THEREOF | 2000 |
|
RU2233328C2 |
ANTIGENES NEISSERIA MENINGITIDIS | 1999 |
|
RU2343159C2 |
ANTIGEN MENINGOCOCCUS PEPTIDES (VARIANTS) | 2000 |
|
RU2253678C2 |
PROTEIN CORRESPONDING TO NEISSERIA MENINGITIDIS ANTIGEN PROTEIN AND ELICITING IMMUNOGENIC PROPERTIES (VARIANTS), ANTIBODY BINDING WITH IT, NUCLEOTIDE SEQUENCE (VARIANTS) AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | 1998 |
|
RU2232191C2 |
Authors
Dates
2008-08-20—Published
2002-12-12—Filed